Clinical Trials Browser

Phase 2/3 × 4-Aminopyridine × 1 year × Clear all

NCT03701581 2025-12-17

4-aminopyridine Treatment for Nerve Injury

Phase 2/3 Recruiting

Erectile Dysfunction, Prostatic Neoplasms